Company / Current Assets
Corcept Therapeutics Incorporated Current Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$485.5M
FY2025
5-year range
$266.5M / $499.3M
FY2021-FY2025
Trend
+2.9%
vs FY2024
Sector context
#118 of 213
Health Care
What the data says
At $485M, Corcept Therapeutics Incorporated's current assets ranks #118 of 213 in the Health Care sector. Current Assets has fluctuated over the past 10 years, ranging from $66M in FY2016 to $499M in FY2022.
Based on SEC 10-K filings.
$485M in FY2025 with a 5-year CAGR of +0.3%.
Improved from $459M to $485M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- -0.9%
- 5-Year CAGR
- +0.3%
- 10-Year CAGR
- -
Sector benchmark
#118 of 213 in Health CareTop 55% of 213This company $485.5M Sector average $2.5B
▼
-80.8% below sector average
Key checks
Key Insights
- 5-year CAGR of +0.3%, indicating consistent growth.
- In FY2025, current assets increased 2.9% year-over-year.
- Ranks #118 out of 213 companies in the Health Care sector.
- Peak current assets was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score 3.44 (safe zone, above 2.9 threshold)
- Strong profit margin: 20.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $485.5M | +2.9% |
| FY2024 | $471.6M | +2.8% |
| FY2023 | $458.6M | -8.1% |
| FY2022 | $499.3M | +87.4% |
| FY2021 | $266.5M | -44.3% |
| FY2020 | $478.5M | +55.7% |
| FY2019 | $307.4M | +29.8% |
| FY2018 | $236.8M | +90.7% |
| FY2017 | $124.2M | +89.0% |
| FY2016 | $65.7M | +34.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026